RetinalGenix Technologies Inc. RTGN
$3.99
-$0.01-0.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.95% | 11.96% | 43.79% | 33.11% | 31.94% |
| Total Depreciation and Amortization | 4.35% | 56.25% | 188.89% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.53% | -10.81% | -49.78% | -33.73% | -42.06% |
| Change in Net Operating Assets | -0.77% | 141.11% | -12.34% | -45.73% | -51.25% |
| Cash from Operations | 37.09% | 37.24% | 24.75% | 27.08% | -35.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -291.30% | -382.14% | -45.27% | -66.57% | -89.67% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -0.31% | -26.65% | -23.14% | -29.43% | 106.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -25.13% | -33.66% | -24.18% | -41.86% | 4.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.81% | 92.49% | 44.26% | -199.75% | -201.18% |